98%
921
2 minutes
20
Obstetric triage systems play a vital role in ensuring timely care for pregnant women, yet their implementation and effectiveness vary across healthcare settings. This systematic review synthesizes evidence on the impact of standardized obstetric triage systems on care timeliness, staff competency, and maternal-fetal outcomes, while examining barriers and facilitators to successful implementation in diverse contexts. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a systematic search across six databases (PubMed, Embase, Scopus, Web of Science, CINAHL, IEEE Xplore). Eligible studies evaluated obstetric triage interventions, reported quantitative or mixed-methods data on implementation/effectiveness outcomes (e.g., time to assessment, length of stay (LOS), staff knowledge), and were peer-reviewed. 11 studies met inclusion criteria and were evaluated using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool for risk of bias; seven were rated as low risk. Due to heterogeneity in interventions, outcomes, and settings (high- vs low-resource), a narrative synthesis was performed. Key findings demonstrated that standardized triage tools significantly reduced the time from patient arrival to initial evaluation by a healthcare provider (time to provider assessment) and LOS in high-resource settings. In low-resource contexts, locally adapted models reduced median waiting times from 40 minutes to five minutes, though systemic barriers like understaffing persisted. Successful implementation relied on staff training and workflow integration, while variability in adoption reflected organizational culture. Limitations included heterogeneity precluding meta-analysis and under-representation of low-resource settings. Obstetric triage standardization enhances care efficiency, but effectiveness depends on contextual adaptation and multidisciplinary engagement. Future research should prioritize randomized controlled trials (RCTs), cost-effectiveness analyses, and tailored strategies for low-resource settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399223 | PMC |
http://dx.doi.org/10.7759/cureus.89215 | DOI Listing |
Arch Gynecol Obstet
September 2025
Department of Obstetrics and Gynecology, University Medical Center Freiburg, Freiburg, Germany.
Objective: To investigate the clinical utility of diagnostic laparoscopy in guiding treatment strategy and surgical outcomes for patients with advanced-stage ovarian cancer, specifically regarding operability assessment and the likelihood of complete cytoreduction.
Methods: This retrospective cohort study analyzed 183 patients with histologically confirmed International Federation of Gynecology and Obstetrics (FIGO) stage III-IV ovarian cancer treated with curative intent between January 2018 and December 2023 at a tertiary referral center. Patients were divided into two groups: those who underwent diagnostic laparoscopy prior to primary treatment (n = 80) and those managed without laparoscopy (n = 103).
PLoS One
September 2025
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Cervical cancer remains the leading cause of cancer death among women in sub-Saharan Africa and is more severe in high HIV-burdened countries due to persistent high-risk human papillomavirus (hrHPV). In 2021, the World Health Organization recommended primary hrHPV testing for cervical cancer screening; however, optimal triage strategies following positive hrHPV tests remain unclear. We conducted a prospective cost analysis of triage methods for positive hrHPV results among women living with and without HIV in Gaborone, Botswana.
View Article and Find Full Text PDFInt J Gynaecol Obstet
September 2025
Oxford Gynecological Cancer Center, Churchill Hospital, Oxford, UK.
Cervical cancer remains a major health burden, particularly in low- and middle-income countries, despite being one of the most preventable cancers. WHO's 90-70-90 targets aim to eliminate cervical cancer globally by 2030. These targets include 90% of girls fully vaccinated with the HPV vaccine by the age of 15 years, 70% of women screened using a high-performance test by the age of 35 years and again by 45 years, and 90% of women with cervical disease receiving appropriate treatment.
View Article and Find Full Text PDFSex Reprod Healthc
August 2025
Center for Clinical Research and Prevention, University Hospital - Bispebjerg-Frederiksberg, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark; Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark. Electronic address: Michaela.louise.schiotz@r
Objectives: To evaluate the Antenatal Risk Questionnaire (ANRQ) and the Edinburgh Postnatal Depression Scale (EPDS) as part of an integrated psychosocial risk assessment aiming to enhance triage for pregnant women needing extended care. Further, to examine differences in sociodemographic and psychosocial characteristics of the population.
Methods: This descriptive study was conducted at Department of Gynecology and Obstetrics, Copenhagen University Hospital - North Zealand,Denmark.
Cureus
August 2025
Obstetrics and Gynecology, Al Kharj Armed Forces Hospital, Al-Kharj, SAU.
Obstetric triage systems play a vital role in ensuring timely care for pregnant women, yet their implementation and effectiveness vary across healthcare settings. This systematic review synthesizes evidence on the impact of standardized obstetric triage systems on care timeliness, staff competency, and maternal-fetal outcomes, while examining barriers and facilitators to successful implementation in diverse contexts. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a systematic search across six databases (PubMed, Embase, Scopus, Web of Science, CINAHL, IEEE Xplore).
View Article and Find Full Text PDF